Kisspeptin-10 Specifications – Purity, Identity & Documentation Guide
Researchers evaluating Kisspeptin-10 specifications should look beyond a product name and a single purity percentage.
A useful research-product evaluation considers several separate characteristics:
Molecular identity
Peptide sequence
Terminal modification
Quantity
Purity
Analytical method
Identity-related testing
Certificate of Analysis
Batch traceability
These characteristics answer different questions about the research material and shouldn’t be treated as interchangeable.
What Is Kisspeptin-10?
Kisspeptin-10, also written as KP-10 or Kp-10, is the 10-amino-acid bioactive fragment associated with the kisspeptin signaling system.
Its sequence is:
YNWNSFGLRF-NH₂
Expanded:
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH₂
The C-terminal amide is part of the molecular description.
Kisspeptin-10 Molecular Specifications
Useful reference information includes:
Compound: Kisspeptin-10
Peptide length: 10 amino acids
Sequence: YNWNSFGLRF-NH₂
CAS: 374675-21-5
These identifiers provide a starting point for evaluating whether a commercial listing corresponds to the intended research peptide.
Why Exact Identity Matters
The term “kisspeptin” can describe the broader family of peptides derived from the KISS1 precursor.
Kisspeptin-10 identifies a specific fragment.
Researchers searching specifically for KP-10 should therefore verify that the product concerns Kisspeptin-10 rather than relying on a general reference to kisspeptin.
Sequence Is Part of the Specification
The amino-acid sequence provides an important molecular reference:
YNWNSFGLRF-NH₂
Sequence information is particularly useful because peptide identity depends on more than simply the words printed on a product label.
Researchers should compare available product information with the expected molecular description.
Why the C-Terminal Amide Matters
The -NH₂ notation at the end of the sequence represents C-terminal amidation.
Terminal modifications can be part of the intended molecular structure of a peptide.
Therefore, the sequence shouldn’t simply be shortened to:
YNWNSFGLRF
when precise molecular identity is being discussed.
Quantity Is a Separate Specification
Kisspeptin-10 research products may be offered in different quantities.
Current product options can be reviewed here:
https://peptideslabus.com/products?q=Kisspeptin-10
Researchers should determine the amount needed according to their experimental design.
Kisspeptin-10 10mg Specifications
Researchers looking specifically for a 10mg research format can review:
https://peptideslabus.com/products/kisspeptin-10-10mg-research-peptide
The live product listing should be used to review applicable specifications and documentation.
Detailed Kisspeptin-10 Specifications
Researchers can also review:
https://peptideslabus.com/products/crown-kisspeptin-10
This listing provides detailed molecular and analytical information relevant to product evaluation.
Kisspeptin-10 5mg and 10mg Specifications
Additional quantity options can be reviewed here:
https://peptideslabus.com/products/peptides-lab-kisspeptin-10-kisspeptin
The listing provides 5mg and 10mg research formats.
Quantity and analytical quality should remain separate considerations.
A 10mg format isn’t automatically higher purity than a 5mg format simply because it contains more material.
Understanding Kisspeptin-10 Purity
Purity describes the proportion of material represented by the target component under the applicable analytical method and reporting framework.
When a purity percentage is displayed, researchers should ask:
- Which analytical method was used?
- Which batch was tested?
- Is the result batch-specific?
- Is supporting documentation available?
- What exactly does the reported value represent?
This provides more information than the percentage alone.
Kisspeptin-10 HPLC Analysis
High-performance liquid chromatography is commonly used in peptide characterization.
HPLC can separate components according to their chromatographic behavior and provide useful information about sample purity.
However:
HPLC purity does not independently prove complete molecular identity.
That distinction is important.
Purity vs Identity
Consider these as separate questions.
Purity asks:
How much of the analyzed sample corresponds to the principal chromatographic component under the stated method?
Identity asks:
Is that material actually the intended Kisspeptin-10 molecule?
A research procurement process should consider both.
Identity-Related Analytical Information
Researchers should review available analytical information that supports molecular identity.
This is especially important when procuring a precisely defined 10-amino-acid peptide.
What Does a COA Add?
A Certificate of Analysis can organize product-specific analytical information.
Depending on the documentation provided, a COA may contain:
- Compound name
- Batch or lot
- Quantity or specification
- Purity
- Analytical method
- Identity-related results
- Additional quality information
The value of a COA depends on what it actually reports.
Batch-Specific Documentation
Peptide analytical results may correspond to a specific production batch.
Researchers should determine whether the available documentation applies to the batch being considered.
A result from one batch shouldn’t automatically be treated as proof of the characteristics of every future batch.
Specifications and KISS1R Research
Kisspeptin-10 is investigated in the context of KISS1R, historically called GPR54.
This receptor terminology provides biological context for experimental design.
It doesn’t replace analytical verification of the research material.
Specifications and GnRH Research
Kisspeptin/KISS1R signaling is strongly associated with GnRH neuronal biology.
Researchers studying this pathway may require Kisspeptin-10 as an experimental material.
However, the existence of scientific literature on GnRH signaling doesn’t establish the identity or purity of a commercial batch.
Specifications and HPG-Axis Research
Kisspeptin research also intersects with the hypothalamic-pituitary-gonadal axis.
Relevant scientific entities include:
- GnRH
- LH
- FSH
- Gonadal steroid feedback
- Reproductive neuroendocrine pathways
These biological relationships should remain distinct from commercial product specifications.
Don’t Use Purity as a Biological Activity Claim
A high reported analytical purity does not independently establish:
- KISS1R activation
- GnRH response
- LH response
- FSH response
- Reproductive effects
- Functional potency
Analytical purity and biological activity are different questions.
Kisspeptin-10 Specification Checklist
Before procurement:
- Confirm the compound is Kisspeptin-10.
- Verify the 10-amino-acid identity.
- Review YNWNSFGLRF-NH₂.
- Check the C-terminal amidation.
- Confirm quantity.
- Determine whether 5mg or 10mg fits the protocol.
- Review reported purity.
- Identify the analytical method.
- Examine HPLC information.
- Review identity-related testing.
- Examine the COA.
- Check batch or lot information.
- Verify current price.
- Confirm current availability.
- Keep analytical specifications separate from biological claims.
Browse Kisspeptin-10 Research Products
https://peptideslabus.com/products?q=Kisspeptin-10
A complete Kisspeptin-10 specification review should consider molecular identity, sequence, terminal modification, quantity, purity, analytical methods, identity-related evidence, COA documentation, and batch traceability.
For laboratory research purposes only.